Common Aging Signature in the Peripheral Blood of Vascular Dementia and Alzheimer’s Disease

[1]  K. Jellinger,et al.  The overlap between vascular disease and Alzheimer’s disease - lessons from pathology , 2014, BMC Medicine.

[2]  Steve Horvath,et al.  Seasonal changes in gene expression represent cell-type composition in whole blood. , 2014, Human molecular genetics.

[3]  Yin-gang Ren,et al.  Serum S100A12 concentrations are correlated with angiographic coronary lesion complexity in patients with coronary artery disease , 2014, Scandinavian journal of clinical and laboratory investigation.

[4]  Markus Perola,et al.  Meta-analysis on blood transcriptomic studies identifies consistently coexpressed protein–protein interaction modules as robust markers of human aging , 2013, Aging cell.

[5]  Toshiko Tanaka,et al.  Changes in splicing factor expression are associated with advancing age in man , 2013, Mechanisms of Ageing and Development.

[6]  K. Tsuchiya,et al.  S100A12 Gene Expression Is Increased in Peripheral Leukocytes in Chronic Kidney Disease Stage 4-5 Patients with Cardiovascular Disease , 2013, Nephron Clinical Practice.

[7]  Y. Huang,et al.  Serum S100A12 Levels Are Correlated With the Presence and Severity of Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus , 2013, Journal of Investigative Medicine.

[8]  J. Trojanowski,et al.  Vascular disease and dementias: Paradigm shifts to drive research in new directions , 2013, Alzheimer's & Dementia.

[9]  Philip Beineke,et al.  A whole blood gene expression-based signature for smoking status , 2012, BMC Medical Genomics.

[10]  G. Waldemar,et al.  Protein Markers for the Differential Diagnosis of Vascular Dementia and Alzheimer's Disease , 2012, International journal of proteomics.

[11]  José M Ferro,et al.  TTC7B Emerges as a Novel Risk Factor for Ischemic Stroke Through the Convergence of Several Genome-Wide Approaches , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  G. Ginsburg,et al.  Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. , 2011, Thrombosis research.

[13]  S. Bandinelli,et al.  Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing , 2011, Aging cell.

[14]  A. Lee,et al.  Vascular Dementia , 2011, Chonnam medical journal.

[15]  L. Hou,et al.  Gene expression variation between African Americans and whites is associated with coronary artery calcification: the multiethnic study of atherosclerosis. , 2011, Physiological genomics.

[16]  J. Li,et al.  Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease , 2011, Neurology.

[17]  Y. Mori,et al.  Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[18]  Szilard Voros,et al.  Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients , 2011, BMC Medical Genomics.

[19]  L. Grinberg,et al.  Toward a pathological definition of vascular dementia , 2010, Journal of the Neurological Sciences.

[20]  Markus Perola,et al.  An Immune Response Network Associated with Blood Lipid Levels , 2010, PLoS genetics.

[21]  W. Chan,et al.  Validation of the new interpretive guidelines for the clinical dementia rating scale sum of boxes score in the national Alzheimer's coordinating center database. , 2010, Archives of neurology.

[22]  Dominique Drouin,et al.  Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression , 2010, Alzheimer's & Dementia.

[23]  Pascal J. Goldschmidt-Clermont,et al.  Gene Expression Patterns in Peripheral Blood Correlate with the Extent of Coronary Artery Disease , 2009, PloS one.

[24]  J. Burke,et al.  Cognitive functioning in Alzheimer's and vascular dementia: a meta-analysis. , 2009, Neuropsychology.

[25]  Regine Heller,et al.  Monocytes of patients with familial hypercholesterolemia show alterations in cholesterol metabolism , 2008, BMC Medical Genomics.

[26]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[27]  J. Growdon,et al.  Molecular markers of early Parkinson's disease based on gene expression in blood , 2007, Proceedings of the National Academy of Sciences.

[28]  Rainer Breitling,et al.  RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..

[29]  B. Engelhardt,et al.  Dysferlin Is a New Marker for Leaky Brain Blood Vessels in Multiple Sclerosis , 2006, Journal of neuropathology and experimental neurology.

[30]  S. Black,et al.  National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards , 2006, Stroke.

[31]  Ash A. Alizadeh,et al.  Individuality and variation in gene expression patterns in human blood , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Kalaria.  Similarities between Alzheimer's disease and vascular dementia , 2002, Journal of the Neurological Sciences.

[33]  Gabriele Siciliano,et al.  Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease , 2002, Neurobiology of Aging.

[34]  Russ B. Altman,et al.  Missing value estimation methods for DNA microarrays , 2001, Bioinform..

[35]  P. Bertolucci,et al.  Quantitative evaluation of the rRNA in Alzheimer's disease , 2000, Mechanisms of Ageing and Development.

[36]  Y. Minemawari,et al.  [Cognitive function and basic activity of daily living of elderly disabled inpatients]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[37]  R. Havlik,et al.  Characterization of risk factors for vascular dementia , 1999, Neurology.

[38]  Amos D. Korczyn,et al.  Vascular dementia , 1993, Journal of the Neurological Sciences.

[39]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[40]  Guangchun Han,et al.  AlzBase: an Integrative Database for Gene Dysregulation in Alzheimer’s Disease , 2014, Molecular Neurobiology.

[41]  D. Mari,et al.  Different adenosine A2A receptor expression in peripheral cells from elderly patients with vascular dementia and Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[42]  Hongxing Lei,et al.  Characteristic transformation of blood transcriptome in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[43]  Lars Lannfelt,et al.  Prediction of mild cognitive impairment that evolves into Alzheimer's disease dementia within two years using a gene expression signature in blood: a pilot study. , 2013, Journal of Alzheimer's disease : JAD.

[44]  Magda Tsolaki,et al.  A blood gene expression marker of early Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[45]  K. Kario,et al.  S100A12 as a marker to predict cardiovascular events in patients with chronic coronary artery disease. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[46]  Zina M. Ibrahim,et al.  Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. , 2012, Journal of Alzheimer's disease : JAD.

[47]  Hongxing Lei,et al.  Down-regulation of energy metabolism in Alzheimer's disease is a protective response of neurons to the microenvironment. , 2012, Journal of Alzheimer's disease : JAD.

[48]  D. Aarsland,et al.  A novel blood test for the early detection of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[49]  M. Smith,et al.  Reduction of the activity of ribosomal genes with age in Down's syndrome. , 1996, Gerontology.

[50]  Z. Y. Wang,et al.  A Chinese version of the Mini-Mental State Examination; impact of illiteracy in a Shanghai dementia survey. , 1988, Journal of clinical epidemiology.

[51]  Andrew E. Jaffe,et al.  Bioinformatics Applications Note Gene Expression the Sva Package for Removing Batch Effects and Other Unwanted Variation in High-throughput Experiments , 2022 .